GeneDx Holdings Corp. (WGS) · INSIDERData sourcesSEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago
Public companyGeneDx Holdings Corp.
WGSCIK 0001818331
Price$62.37
1 year-54.4%
Disclosed transactions60
Buys / sells0 / 34
Max Insider Score28
Connections with evidence7
WGS · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 28 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $407K 4,141 sh | Sep 16, 2026 | Sep 18, 2026 |
| 22 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $52K 541 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 9 | | WGSGeneDx Holdings Corp. Option exercise | M | — 1,146 sh | Sep 17, 2026 | Sep 18, 2026 traded Sep 17, 2026 | +1d | SEC Form 4 | |
| 22 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $14K 148 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 28 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $301K 3,039 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 22 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $107K 1,079 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 19 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $4,961 52 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 25 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $148K 1,525 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 22 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $55K 586 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 9 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 18.8K sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 6 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 7,197 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 25 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $155K 1,648 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 17 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 18.8K sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 21 | | WGSGeneDx Holdings Corp. Option exercise | M | — 1,146 sh | Sep 17, 2026 | Sep 18, 2026 traded Sep 17, 2026 | +1d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 7,197 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 22 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $144K 1,470 sh | Sep 16, 2026 | Sep 18, 2026 traded Sep 16, 2026 | +2d | SEC Form 4 | |
| 9 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 6,547 sh | Sep 9, 2026 | Sep 11, 2026 traded Sep 9, 2026 | +2d | SEC Form 4 | |
| 5 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 6,547 sh | Sep 9, 2026 | Sep 11, 2026 traded Sep 9, 2026 | +2d | SEC Form 4 | |
| 6 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 2,462 sh | Sep 9, 2026 | Sep 11, 2026 traded Sep 9, 2026 | +2d | SEC Form 4 | |
| 28 | SKStueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $311K 3,692 sh | Sep 9, 2026 | Sep 11, 2026 traded Sep 9, 2026 | +2d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 2,462 sh | Sep 9, 2026 | Sep 11, 2026 traded Sep 9, 2026 | +2d | SEC Form 4 | |
| 22 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $108K 1,285 sh | Sep 9, 2026 | Sep 11, 2026 traded Sep 9, 2026 | +2d | SEC Form 4 | |
| 9 | GAGardner Mark APresident | WGSGeneDx Holdings Corp. Grant or award | A | — 35.4K sh | Jun 29, 2026 | Jul 1, 2026 traded Jun 29, 2026 | +2d | SEC Form 4 | |
| 15 | | WGSGeneDx Holdings Corp. Grant or award | A | — 4,248 sh | Jun 18, 2026 | Jun 23, 2026 traded Jun 18, 2026 | +5d | SEC Form 4 | |
| 6 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 7,197 sh | Jun 16, 2026 | Jun 18, 2026 traded Jun 16, 2026 | +2d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 7,197 sh | Jun 16, 2026 | Jun 18, 2026 traded Jun 16, 2026 | +2d | SEC Form 4 | |
| 17 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $53K 863 sh | Jun 16, 2026 | Jun 18, 2026 traded Jun 16, 2026 | +2d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $45K 760 sh | Jun 16, 2026 | Jun 18, 2026 traded Jun 16, 2026 | +2d | SEC Form 4 | |
| 17 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $128K 2,106 sh | Jun 16, 2026 | Jun 18, 2026 traded Jun 16, 2026 | +2d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 2,462 sh | Jun 9, 2026 | Jun 11, 2026 traded Jun 9, 2026 | +2d | SEC Form 4 | |
| 17 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $68K 1,266 sh | Jun 9, 2026 | Jun 11, 2026 traded Jun 9, 2026 | +2d | SEC Form 4 | |
| 6 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 2,462 sh | Jun 9, 2026 | Jun 11, 2026 traded Jun 9, 2026 | +2d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $26K 392 sh | Apr 29, 2026 | May 1, 2026 traded Apr 29, 2026 | +2d | SEC Form 4 | |
| 2 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 754 sh | Apr 29, 2026 | May 1, 2026 traded Apr 29, 2026 | +2d | SEC Form 4 | |
| 2 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 754 sh | Apr 29, 2026 | May 1, 2026 traded Apr 29, 2026 | +2d | SEC Form 4 | |
| 17 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $60K 961 sh | Mar 26, 2026 | Mar 30, 2026 traded Mar 26, 2026 | +4d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 16.3K sh | Mar 26, 2026 | Mar 30, 2026 traded Mar 26, 2026 | +4d | SEC Form 4 | |
| 21 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $152K 2,485 sh | Mar 26, 2026 | Mar 30, 2026 traded Mar 26, 2026 | +4d | SEC Form 4 | |
| 17 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $64K 995 sh | Mar 26, 2026 | Mar 30, 2026 traded Mar 26, 2026 | +4d | SEC Form 4 | |
| 21 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $159K 2,520 sh | Mar 26, 2026 | Mar 30, 2026 traded Mar 26, 2026 | +4d | SEC Form 4 | |
| 21 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $121K 1,857 sh | Mar 26, 2026 | Mar 30, 2026 traded Mar 26, 2026 | +4d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 16.3K sh | Mar 26, 2026 | Mar 30, 2026 traded Mar 26, 2026 | +4d | SEC Form 4 | |
| 6 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 2,462 sh | Mar 9, 2026 | Mar 11, 2026 traded Mar 9, 2026 | +2d | SEC Form 4 | |
| 10 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 2,462 sh | Mar 9, 2026 | Mar 11, 2026 traded Mar 9, 2026 | +2d | SEC Form 4 | |
| 21 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $111K 1,280 sh | Mar 9, 2026 | Mar 11, 2026 traded Mar 9, 2026 | +2d | SEC Form 4 | |
| 9 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Grant or award | A | $175K 1,986 sh | Mar 6, 2026 | Mar 9, 2026 traded Mar 6, 2026 | +3d | SEC Form 4 | |
| 2 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Grant or award | A | — 10.9K sh | Mar 3, 2026 | Mar 5, 2026 traded Mar 3, 2026 | +2d | SEC Form 4 | |
| 21 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $176K 2,220 sh | Mar 4, 2026 | Mar 5, 2026 traded Mar 4, 2026 | +1d | SEC Form 4 | |
| 21 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $111K 1,424 sh | Mar 4, 2026 | Mar 5, 2026 traded Mar 4, 2026 | +1d | SEC Form 4 | |
| 14 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Grant or award | A | — 15.3K sh | Mar 3, 2026 | Mar 5, 2026 traded Mar 3, 2026 | +2d | SEC Form 4 | |
| 21 | FKFeeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $200K 2,543 sh | Mar 4, 2026 | Mar 5, 2026 traded Mar 4, 2026 | +1d | SEC Form 4 | |
| 2 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Grant or award | A | — 10.4K sh | Mar 3, 2026 | Mar 5, 2026 traded Mar 3, 2026 | +2d | SEC Form 4 | |
| 21 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale · 10b5-1 plan | SELL | $138K 1,572 sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 18 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale · 10b5-1 plan | SELL | $9,045 100 sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 18 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale · 10b5-1 plan | SELL | $29K 328 sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 17 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale · 10b5-1 plan | SELL | $54K 623 sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 17 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale · 10b5-1 plan | SELL | $119K 1,425 sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 18 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale · 10b5-1 plan | SELL | $9,192 100 sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 13 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale · 10b5-1 plan | SELL | $65K 779 sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
| 17 | DBDechairo BryanChief Operating Officer | WGSGeneDx Holdings Corp. Open-market sale · 10b5-1 plan | SELL | $88K 1,034 sh | Feb 4, 2026 | Feb 6, 2026 traded Feb 4, 2026 | +2d | SEC Form 4 | |
Chief Operating Officer · Feb 3, 2026
Planned sales and 5% stakes
Form 144, 13D and 13G